PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2018.0842019511158-168Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung AdenocarcinomaIn Kyoung Hwang, Seung Sook Paik, Seung Hyeun Leehttp://e-crt.org/upload/pdf/crt-2018-084.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.084, http://www.e-crt.org/upload/pdf/crt-2018-084.pdf
The Journal of Thoracic and Cardiovascular Surgery10.1016/j.jtcvs.2017.07.053201715451766-1767EGFR mutational status in lung adenocarcinoma: Staging implications or continuous evolution?Winifred M. Lo, R. Taylor Ripleyhttps://api.elsevier.com/content/article/PII:S0022522317317063?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022522317317063?httpAccept=text/plain
Journal of Thoracic Oncology10.1016/j.jtho.2019.08.179020191410S831P2.14-05 EGFR Mutation Status and Prognostic Impact in Patients with Surgically Resected Lung AdenocarcinomaY. Tokunaga, Y. Kita, T. Okamotohttps://api.elsevier.com/content/article/PII:S1556086419324736?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086419324736?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdx729201728x183Analysis of EGFR mutation status in blood and CSF in lung adenocarcinoma patients with EGFR mutation and CNS metastasis by ddPCRY. Sen, Q. Wanghttps://api.elsevier.com/content/article/PII:S0923753419565462?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419565462?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/28/suppl_10/mdx729/21937233/mdx729.pdf
Clinical Lung Cancer10.1016/j.cllc.2020.10.0192020Progression patterns of metastatic lung adenocarcinoma patients with EGFR mutationShinichiro Okauchi, Katsunori Kagohashi, Toshihiro Shiozawa, Kunihiko Miyazaki, Hiroaki Satohhttps://api.elsevier.com/content/article/PII:S1525730420303296?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730420303296?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(13)70016-3201379S616 EGFR mutational analysis for adenocarcinoma of the lung; outcome by mutation since the introduction of routine molecular testing in one cancer networkA.F.C. Okines, P. Brulinski, D. Gonzalez de Castro, R. Shahhttps://api.elsevier.com/content/article/PII:S0169500213700163?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213700163?httpAccept=text/plain
Radiology and Oncology10.2478/raon-2014-00162014482173-183Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survivalKarmen Stanic, Matjaz Zwitter, Nina Turnsek Hitij, Izidor Kern, Aleksander Sadikov, Tanja Cuferhttp://content.sciendo.com/view/journals/raon/48/2/article-p173.xml, https://www.degruyter.com/view/j/raon.2014.48.issue-2/raon-2014-0016/raon-2014-0016.pdf
Tuberculosis and Respiratory Diseases10.4046/trd.2018.0004201982162Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung AdenocarcinomaSeo Yun Kim, Jae Kyung Myung, Hye-Ryoun Kim, Im Il Na, Jae Soo Koh, Hee Jong Baek, Cheol Hyeon Kimhttps://synapse.koreamed.org/pdf/10.4046/trd.2018.0004, https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2018.0004, https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2018.0004
Clinical Lung Cancer10.1016/j.cllc.2017.01.0092017183316-323.e1Non–Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non–Small-cell Lung Cancer Favor AdenocarcinomaIris Shiran, Eyal Heller, Shlomit Jessel, Iris Kamer, Inbal Daniel-Meshulam, Rossie Navon, Damien Urban, Amir Onn, Jair Barhttps://api.elsevier.com/content/article/PII:S1525730417300384?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730417300384?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2018.03.0132018119120-126Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patientsShoji Yomo, Kyota Odahttps://api.elsevier.com/content/article/PII:S0169500218303027?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500218303027?httpAccept=text/plain